Hosted By
In this special Cambridge Tech Week podcast episode we chat to Umaima Ahmad, CEO and co-founder of 52North, a multi-award winning med-tech company focused on reinventing the healthcare journey, starting by transforming cancer care with Neutrocheck®. She shares lessons learned from the early days of Neutrocheck to the company recently being the first ever venture investment of Macmillan Cancer Support.
Hear how Umaima moved from a successful career as a finance lawyer into the world of entrepreneurship and healthcare, via her role in business development at AstraZeneca. She tells us about how the idea came about, the importance of good hires and provides some tips on securing early investors.
In this latest start-up stories episode we’re talking with Jim McDougall, the co-founder of Outfield Technologies, an exciting start-up making a real impact to...
We recently spoke to Cambridge Angels, Simon Thorpe and Phil O'Donovan about what they do, what makes a good investment and why Cambridge is...
We're excited to share the latest episode of the ideaSpace Podcast, featuring special guest Scott White. Scott is a true deep tech pioneer —...
